How Do Steroids Like Prednisone Cause Osteoporosis?
At a Glance
Prednisone causes glucocorticoid-induced osteoporosis by slowing bone-building cells, briefly increasing bone breakdown, and harming cells that maintain bone. Bone loss and spinal fracture risk can rise within months, making early risk assessment and prevention important.
In this answer
3 sections
Steroids like prednisone cause glucocorticoid-induced osteoporosis (GIOP) primarily by shutting down the cells that build new bone, while causing an early spike in the cells that break it down [1][2]. This creates an imbalance in your natural bone remodeling process, leading to a rapid loss of bone density and strength [3][4].
Your bones are living tissue, constantly being broken down and rebuilt in a tightly controlled cycle. When you take systemic glucocorticoids (steroids that travel through your whole body) like prednisone for an autoimmune disease, the medication directly interferes with this cycle.
Important Safety Warning: Never stop taking prednisone abruptly or change your dose without your doctor’s guidance. Suddenly stopping steroids can cause a dangerous condition called adrenal insufficiency and may cause your underlying autoimmune disease to flare up.
The Rapid Timeline of Bone Loss
Unlike typical age-related osteoporosis, which develops gradually over years, GIOP happens very quickly. The most rapid phase of bone loss occurs within the first few months of starting long-term steroid therapy [5].
Fracture risk—especially in the spine (vertebral fractures)—rises significantly within the first six months of exposure [5]. Even relatively low daily doses of steroids have been associated with a higher risk of these spine fractures [6]. Importantly, many vertebral fractures are “silent” and cause no obvious pain, though they can lead to height loss over time. If you experience new, severe, or persistent back pain, or sudden loss of height, contact your clinician promptly for an evaluation.
How Steroids Disrupt Your Bone Cells
Steroids impact three main types of bone cells, triggering bone loss from multiple angles:
- Osteoblasts (Bone Builders): This is the primary driver of GIOP. Steroids actively suppress the function and survival of osteoblasts [1][3]. Over time, fewer new bone-forming cells are available to replace old bone [4][7].
- Osteoclasts (Bone Breakers): Early in steroid treatment, the medication increases the production of a signal called RANKL [2]. This signal stimulates osteoclasts—the cells responsible for breaking down old bone—causing an initial spike in bone resorption.
- Osteocytes (Bone Managers): Osteocytes are cells embedded deep within the bone that act as a sensory network, detecting mechanical stress. Steroids can cause the early death (apoptosis) of these cells [8]. This disrupts your bone’s structural network and impairs its ability to repair itself.
Prevention and Proactive Management
Because bone damage begins so quickly, guidelines recommend a prompt fracture-risk assessment for adults starting a prolonged course of steroids (such as several months of treatment) [9]. You do not automatically need medication just because you take prednisone, but early assessment helps your care team decide if treatment is warranted based on your specific health profile.
Standard prevention and management strategies include:
- Risk Assessment and Scans: Your doctor will evaluate your age, dose, duration of steroid use, and prior fracture history [9]. They may order a DEXA scan (a low-dose X-ray that measures bone density) or spine imaging to check for silent fractures [9].
- Bone-Protecting Medications: If your overall fracture risk is high, your doctor may prescribe medications like bisphosphonates to protect your bones [10][11]. For individuals at very high risk, anabolic (bone-building) therapies might be considered as an option, depending on other health factors and medical history [9].
- Calcium and Vitamin D: It is important to optimize your calcium and vitamin D intake. While you should aim to get this from your diet, supplements may be needed if your intake or blood levels are low [12][13]. However, high-dose supplements are not for everyone (especially those with a history of kidney disease or kidney stones), and supplements alone cannot prevent steroid-related fractures.
- Lifestyle Adjustments: Weight-bearing and resistance exercises can help maintain bone strength, while balance training reduces the risk of falls [13]. Quitting smoking and limiting alcohol intake also protect your bones [13]. (Always check with your doctor before starting a new exercise program, especially if you have had a prior fracture).
Common questions in this guide
Why can prednisone cause bone loss so quickly?
When does fracture risk rise after starting long-term steroids?
Should I get a DEXA scan before or after starting prednisone?
Can calcium and vitamin D prevent osteoporosis from prednisone?
What medicines protect bones during prednisone treatment?
Can I stop prednisone to protect my bones?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Related questions
Show more
Get notified when new evidence is published on osteoporosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Should I have a baseline DEXA scan or spine imaging to assess my fracture risk now that I am starting long-term prednisone?
- 2.Based on my steroid dose, duration, and personal risk factors, do you recommend starting a preventative osteoporosis medication?
- 3.What are my specific daily calcium and vitamin D goals, and should I use supplements to reach them?
- 4.What lifestyle changes, such as specific weight-bearing exercises, are safe and recommended for me?
- 5.How will my bone health monitoring and treatment plan change when we begin to taper down my prednisone dose?
References
References (13)
- 1
High fracture risk patients with glucocorticoid-induced osteoporosis should get an anabolic treatment first.
Lespessailles E, Chapurlat R
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2020; (31(10)):1829-1834 doi:10.1007/s00198-020-05568-w.
PMID: 32780152 - 2
Glucocorticoid Receptor Regulates TNFSF11 Transcription by Binding to Glucocorticoid Responsive Element in TNFSF11 Proximal Promoter Region.
Lovšin N, Marc J
International journal of molecular sciences 2021; (22(3)) doi:10.3390/ijms22031054.
PMID: 33494362 - 3
WNT7B overexpression rescues bone loss caused by glucocorticoids in mice.
Chen H, Song F, Long F
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2021; (35(7)):e21683 doi:10.1096/fj.202100151RR.
PMID: 34118078 - 4
Exosomes derived from vascular endothelial cells antagonize glucocorticoid-induced osteoporosis by inhibiting ferritinophagy with resultant limited ferroptosis of osteoblasts.
Yang RZ, Xu WN, Zheng HL, et al.
Journal of cellular physiology 2021; (236(9)):6691-6705 doi:10.1002/jcp.30331.
PMID: 33590921 - 5
Effects of Systemic Glucocorticoid Use on Fracture Risk: A Population-Based Study.
Koh JW, Kim J, Cho H, et al.
Endocrinology and metabolism (Seoul, Korea) 2020; (35(3)):562-570 doi:10.3803/EnM.2020.659.
PMID: 32981298 - 6
Low-dose oral glucocorticoid therapy and risk of osteoporotic fractures in patients with rheumatoid arthritis: a cohort study using the Clinical Practice Research Datalink.
Abtahi S, Driessen JHM, Burden AM, et al.
Rheumatology (Oxford, England) 2022; (61(4)):1448-1458 doi:10.1093/rheumatology/keab548.
PMID: 34255815 - 7
CUL1 exacerbates glucocorticoid-induced osteoporosis by enhancing ASAP1 ubiquitination.
Wu J, Ren W, Liu J, Bai X
Hormones (Athens, Greece) 2025; (24(1)):259-274 doi:10.1007/s42000-024-00599-y.
PMID: 39287759 - 8
Pinocembrin alleviates glucocorticoid-induced apoptosis by activating autophagy via suppressing the PI3K/Akt/mTOR pathway in osteocytes.
Wang XY, Gong LJ, Huang JM, et al.
European journal of pharmacology 2020; (880()):173212 doi:10.1016/j.ejphar.2020.173212.
PMID: 32470335 - 9
Extensive expertise in endocrinology: advances in the management of glucocorticoid-induced osteoporosis.
Compston JE
European journal of endocrinology 2023; (188(3)):R46-R55 doi:10.1093/ejendo/lvad029.
PMID: 36880157 - 10
Effectiveness of Oral Bisphosphonates in Reducing Fracture Risk Among Oral Glucocorticoid Users: Three Matched Cohort Analyses.
Amiche MA, Lévesque LE, Gomes T, et al.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2018; (33(3)):419-429 doi:10.1002/jbmr.3318.
PMID: 29068496 - 11
The efficiency and safety of alendronate versus teriparatide for treatment glucocorticoid-induced osteoporosis: A meta-analysis and systematic review of randomized controlled trials.
Liu ZM, Zhang M, Zong Y, et al.
PloS one 2022; (17(5)):e0267706 doi:10.1371/journal.pone.0267706.
PMID: 35639783 - 12
German Society of Rheumatology recommendations for management of glucocorticoid-induced osteoporosis.
Leipe J, Holle JU, Weseloh C, et al.
Zeitschrift fur Rheumatologie 2021; (80(Suppl 2)):49-63 doi:10.1007/s00393-021-01025-z.
PMID: 34705070 - 13
Glucocorticoid-induced Osteoporosis.
Whittier X, Saag KG
Rheumatic diseases clinics of North America 2016; (42(1)):177-89, x.
PMID: 26611558
This page explains how prednisone and other systemic steroids affect bones for informational purposes only and does not constitute medical advice. Do not stop or change prednisone without guidance from your prescribing clinician.